ClinicalTrials.Veeva

Menu

Facing Eating Disorder Fears for Anorexia Nervosa (FED-F)

University of Louisville (UOFL) logo

University of Louisville (UOFL)

Status

Enrolling

Conditions

Anorexia Nervosa in Remission
Eating Disorders
Anorexia Nervosa

Treatments

Behavioral: Facing Eating Disorder Fears Condition

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT05596799
1R34MH126965-01A1 (U.S. NIH Grant/Contract)
IRB#: 21.0992

Details and patient eligibility

About

FED-F is a modular treatment that enhances exposure therapy with psychoeducation and cognitive skills teaching how to face fears of (a) food, (b) weight gain, (c) interoception/body, and (d) social situations. The study goals are to (1) refine and test the acceptability and feasibility of FED-F treatment (Phase I), (2) test if this treatment outperforms treatment as usual (TAU) delivered post-acute treatment as adjunctive to stepdown specialty care (Phase II), and (3) to examine if treatment targets the hypothesized mechanism of action: approach behaviors (Phase II). These goals will lead to a highly deployable and accessible virtual treatment targeted at core AN mechanisms that predict relapse. Specific aims are to (1) refine FED-F into a fully virtual format with input from patients and stakeholders and collect preliminary data (N=10) on its feasibility and acceptability (Phase I), (2) conduct a small pilot RCT (randomized controlled trial) of FED-F (n=30) as compared to TAU (n=30; Phase II), and (3) examine if FED-F targets approach/avoidance behaviors and test if this mechanism is associated with clinical outcomes (Phase II).

Enrollment

70 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18-65
  • Meets criteria for DSM-5 defined AN, AN partial remission, or AN full remission, Atypical Anorexia Nervosa (AAN), AAN partial remission, or AAN full remission
  • Has been discharged from intensive (i.e., inpatient, residential, or partial hospital program) in the past 6 months

Exclusion criteria

  • Under 18
  • Over 65
  • Does not meet criteria for DSM-5 defined AN, AN partial-remission, or AN full-remission
  • High and active Suicidality
  • Active Mania
  • Active psychosis
  • Medically Compromised Status including extremely low weight (less than or equal to 75% median BMI for age, sex, and height)
  • Does not meet criteria for DSM-5 defined AN, AN partial remission, or AN full remission, AAN, AAN partial remission, or AAN full remission
  • Has not been discharged from intensive (i.e., inpatient, residential, or partial hospital program) in the past 6 months

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Facing Eating Disorder Fears Condition
Experimental group
Description:
Participants will complete 1 session of education about the treatment. After completion of treatment education and baseline questionnaires, participants will complete sessions 2 through 12 of virtual treatment for anorexia nervosa and mobile assessments.
Treatment:
Behavioral: Facing Eating Disorder Fears Condition
Treatment as Usual
No Intervention group
Description:
Participants will complete baseline measures, mobile assessments and treatment as usual.

Trial contacts and locations

1

Loading...

Central trial contact

Abigail M McCarthy, B.S.; Cheri A Levinson, Ph.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems